{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:51:35Z","timestamp":1776487895746,"version":"3.51.2"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Calcium has several physiological functions and when it registers abnormal serum levels those functions may be impacted with potentially severe consequences. There is much research on hypercalcemia in cancer patients, but there are no recent studies on the prevalence of hypocalcemia in those patients. However, there has been an evolution in oncology, namely, new drugs that may directly or indirectly result in hypocalcemia. The primary aim was to explore the association of hypocalcemia with the diverse types of cancer. The secondary aim was to study the influence that hypocalcemia might have on survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Review of the records of patients \u226518 years old, with total calcium &lt;2.0\u200ammol\/L measured in 2013 in a cancer center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eight hundred twenty-nine patients were included. Four hundred thirty-nine (53%) were male. The median age was 63 years. The most frequent cancer diagnoses were hematological 196 (24%) and colorectal 111 (13%). Six hundred thirty-eight patients had measured serum albumin, with a median of 25.5\u200ag\/L (14\u201347). When corrected for albumin level, calcium was in the normal range in 210 (33%) cases. The median survival of patients with corrected calcium lower than normal was 479 days (95% confidence interval [CI]: 309\u2013649) and that of patients with normal corrected calcium was 62 days (95% CI: 33\u201391), <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001. In a multivariate analysis, age, primary cancer, and albumin were significantly associated with survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Hypocalcemia is associated with several types of cancer. A low calcium level is not by itself a factor of a poor prognosis since other factors seem to be more important.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/j.pbj.0000000000000045","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T07:09:44Z","timestamp":1564124984000},"page":"e45","source":"Crossref","is-referenced-by-count":20,"title":["Hypocalcemia in cancer patients: An exploratory study"],"prefix":"10.1097","volume":"4","author":[{"given":"Jos\u00e9 Ant\u00f3nio","family":"Ferraz Gon\u00e7alves","sequence":"first","affiliation":[{"name":"Instituto Portugu\u00eas de Oncologia, Porto, Portugal"}]},{"given":"Telma","family":"Costa","sequence":"additional","affiliation":[{"name":"Instituto Portugu\u00eas de Oncologia, Porto, Portugal"}]},{"given":"Joana","family":"Rema","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de S. Jo\u00e3o, Porto, Portugal"}]},{"given":"Cristina","family":"Pinto","sequence":"additional","affiliation":[{"name":"Hospital de Faro, Faro, Portugal"}]},{"given":"Miguel","family":"Magalh\u00e3es","sequence":"additional","affiliation":[{"name":"USF Bar\u00e3o de Nova Sintra, Porto, Portugal"}]},{"given":"Ana","family":"Esperan\u00e7a","sequence":"additional","affiliation":[{"name":"USF Mais Sa\u00fade, Ponte de Lima, Portugal"}]},{"given":"Luciana","family":"Sousa","sequence":"additional","affiliation":[{"name":"Hospital de Braga, Braga, Portugal."}]}],"member":"276","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00774-009-0119-x","article-title":"A review of drug-induced hypocalcemia","volume":"27","author":"Liamis","year":"2009","journal-title":"Bone Miner Metab."},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cam4.749","article-title":"Prevalence of hypercalcemia among cancer patients in the United States","volume":"5","author":"Gastanaga","year":"2016","journal-title":"Cancer Med."},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.canep.2015.10.012","article-title":"Prevalence of hypercalcemia of malignancy among cancer patients in the UK: analysis of the Clinical Practice Research Datalink database","volume":"39","author":"Lick","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1097-0142(19930215)71:4<1309::AID-CNCR2820710423>3.0.CO;2-M","article-title":"Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer","volume":"71","author":"Vassilopoulou-Sellin","year":"1993","journal-title":"Cancer."},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0885066611411543","article-title":"Hypocalcemia in the critically ill patient","volume":"28","author":"Kelly","year":"2013","journal-title":"J Intensiv Care Med."},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.0954-6820.1986.tb02745.x","article-title":"A hospital survey of hypocalcemia in patients with malignant disease","volume":"220","author":"Blomqvist","year":"1986","journal-title":"Acta Med Scand."},{"key":"R7-20230824","first-page":"284","article-title":"Chemotherapy-induced hypocalcemia","volume":"16","author":"Ajer","year":"2010","journal-title":"EndocrPract."},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00520-014-2142-2","article-title":"The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases","volume":"22","author":"Lechner","year":"2014","journal-title":"Support Care Cancer."},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mehy.2011.12.002","article-title":"Bisphosphonate stimulation of osteoblasts and osteoblastic metastasis as a mechanism of hypocalcaemia","volume":"78","author":"Ho","year":"2012","journal-title":"Med Hypotheses."},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1634\/theoncologist.2008-0227","article-title":"High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid","volume":"14","author":"Zuradelli","year":"2009","journal-title":"Oncologist."},{"key":"R11-20230824","first-page":"38","article-title":"Long-term consequences of chronic proton pump inhibitor use","volume":"38","author":"O\u2019Neill","year":"2013","journal-title":"US Pharm."},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/qjmed\/hcq021","article-title":"Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series","volume":"103","author":"Mackay","year":"2010","journal-title":"Q J Med."},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4081\/rt.2014.5389","article-title":"Tumor lysis syndrome in solid tumors: an up to date review of the literature","volume":"6","author":"Mirrakhimov","year":"2014","journal-title":"Rare Tumors."},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","article-title":"Tumor lysis syndrome: new challenges and recent advances","volume":"21","author":"Wilson","year":"2014","journal-title":"Adv Chronic Kidney Dis."},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1089\/jpm.2013.0389","article-title":"Hungry bone syndrome: persistent hypocalcemia related to osteoblastic bone metastases of prostate cancer","volume":"16","author":"Riveros","year":"2013","journal-title":"J Palliat Med."},{"key":"R16-20230824","first-page":"138","article-title":"Hypocalcemia with bony metastases in prostate cancer","volume":"20","author":"Pusulari","year":"2008","journal-title":"J Ayub Med Coll Abbottabad."},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/030089169107700403","article-title":"A hospital survey of hypocalcemia and hyperphosphatemia in malignancy","volume":"77","author":"D\u2019Erasmo","year":"1991","journal-title":"Tumori."},{"key":"R18-20230824","first-page":"231","article-title":"Hypocalcaemia of malignancy","volume":"74","author":"Schattner","year":"2016","journal-title":"Neth J Med."},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1200\/jco.2005.23.16_suppl.6719","article-title":"Incidence of hypocalcemia in multiple myeloma patients after autologous stem cell transplantation","volume":"23","author":"Ford","year":"2005","journal-title":"J Clin Oncol."},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1752-1947-8-353","article-title":"Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report","volume":"8","author":"Aldave","year":"2014","journal-title":"J Med Case Rep."},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<201::AID-AJH1>3.0.CO;2-1","article-title":"Acid-base and electrolyte abnormalities in patients with acute leukemia","volume":"62","author":"Milionis","year":"1999","journal-title":"Am J Hematol."},{"issue":"(suppl)","key":"R22-20230824","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1002\/cncr.24351","article-title":"Predictive models in palliative care","volume":"115","author":"Ripamonti","year":"2009","journal-title":"Cancer."},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/0148607104028003133","article-title":"Accuracy of methods to estimate ionized and \u201ccorrected\u201d serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support","volume":"28","author":"Dickerson","year":"2004","journal-title":"J Parenter Enteral Nutr."}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02054639-201908000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:45:21Z","timestamp":1692841521000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02054639-201908000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/j.pbj.0000000000000045","relation":{},"ISSN":["2444-8664"],"issn-type":[{"value":"2444-8664","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}